Michael Filbin
Director of Clinical Research · Mass General Brigham
Credentials: · · · ·
History
- Present
Clinical Research · Mass General Brigham
- Present
Clinical Research in Emergency Medicine · Massachusetts General Hospital
- Present
Mass General Brigham · Massachusetts General Hospital
- 1994–1998
Research
A randomized trial of protocol-based care for early septic shock
New England Journal of Medicine · 2014 · 1,818 citations
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
Science · 2020 · 536 citations
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Nature · 2022 · 485 citations
28 papers
17 papers
13 papers · 13 as a fellow
- CR
13 papers
13 papers
- KL
11 papers
11 papers
- AR
10 papers
Grants
- 2021–2027
Single-Cell Genomic Profiling to Identify Immune Signatures of Bacterial Sepsis in Humans
National Institute of Allergy and Infectious Diseases · R01
PI · $5M · Massachusetts General Hospital
- 2023–2026
National Institute of General Medical Sciences · R33
Contact PI · $1.3M · Massachusetts General Hospital
- 2023–2024
National Institute of General Medical Sciences · R21
Contact PI · $417.8K · Massachusetts General Hospital
Clinical trials
- 2014–2017
Early Goal Directed Therapy in Sepsis by Emergency Medical Services
Principal investigator · Withdrawn
Massachusetts General Hospital
- 2026–2028
Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock
Site PI · Not yet recruiting · Phase 4
Wake Forest University Health Sciences
- 2026–2029
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Site PI · Recruiting · Phase 3
University of Virginia